Your session is about to expire
← Back to Search
mHRME (Mobile High resolution microendoscope) for Anal Squamous Intraepithelial Lesions
Study Summary
This trial is testing a new, portable microendoscope that takes subcellular images of the anal epithelium to look for changes associated with neoplasia (abnormal tissue growth). The investigators hypothesis is that this 'optical' approach will be more efficient and have a greater clinical impact than the standard of HRA (High resolution anoscopy)-guided biopsy.
- Anal High-Grade Squamous Intraepithelial Lesions
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does the FDA recognize mHRME as a safe and effective medical device?
"The safety of mHRME was given a 2. This is due to the fact that, while there are Phase 2 trials underway testing its safety, there are no such studies investigating whether or not the mobile high resolution microendoscope is effective."
Is this research project still recruiting individuals?
"That is correct. The information available on clinicaltrials.gov indicates that this study, which was originally posted on 7/1/2019, is still recruiting patients. They are looking for 200 individuals from 2 separate locations."
How many people are allowed to be in this trial at any given time?
"That is correct. The clinical trial in question, as reflected on the website clinicaltrials.gov, appears to be currently recruiting patients. This specific study was first published on 7/1/2019 and was most recently updated on 9/7/2021. They are looking for 200 volunteers at 2 different locations."
Share this study with friends
Copy Link
Messenger